Digital Pathology Market by Product (Scanner, Software, Storage System), Type (Human, Veterinary), Application (Teleconsultation, Training, Disease Diagnosis, Drug Discovery), End User (Pharma & Biotech, Academia, Hospitals) - Global Forecast to 2030

1.1 Study Objectives
1.2 Market Definition
1.2.1 Inclusions & Exclusions
1.3 Market Scope
1.3.1 Markets Covered
1.3.2 Years Considered
1.3.3 Currency Considered
1.4 Stakeholders
1.5 Summary of Changes

2.1 Research Approach
2.1.1 Secondary Data
2.1.1.1 Key Data from Secondary Sources
2.1.2 Primary Data
2.1.2.1 Key Data from Primary Sources
2.1.2.2 Key Industry Insights
2.2 Research Methodology Design
2.3 Market Size Estimation
2.4 Market Breakdown and Data Triangulation
2.5 Research Assumptions
2.6 Market Assumptions
2.6.1 Overall Study Assumptions
2.7 Risk Assessment
2.8 Research Limitations
2.8.1 Methodology-Related Limitations
2.8.2 Scope-Related Limitations

4.1 Digital Pathology Market Overview
4.2 North America: Digital Pathology Market, by End-user and Country (2024)
4.3 Digital Pathology Market: Geographic Growth Opportunities
4.4 Digital Pathology Market: Regional Mix

5.1 Introduction
5.2 Market Dynamics
5.2.1 Drivers
5.2.1.1 AI-Enabled Digital Pathology Improving Lab Throughput
5.2.1.2 Rising Burden of Cancer, Diabetes, and Cardiovascular Diseases
5.2.1.3 Expansion of Digital Pathology in Drug Discovery and Biomarker Validation
5.2.1.4 National Cancer Screening Programs in Emerging Markets
5.2.2 Restraints
5.2.2.1 High Initial Capital Cost of Digital Pathology Systems
5.2.2.2 Data Interoperability Issues with Existing Lab Systems
5.2.2.3 Regulatory and Reimbursement Uncertainty
5.2.3 Opportunities
5.2.3.1 Affordable Scanner Development for Low-Resource Settings
5.2.3.2 Personalized Medicine Driving Precision Diagnostics
5.2.3.3 Government-Backed Digitalization in Emerging Economies
5.2.4 Challenges
5.2.4.1 Shortage of Skilled Pathologists and Technicians
5.2.4.2 Algorithm Validation and Trust in AI-based Diagnostics
5.2.4.3 Data Security and Privacy Concerns
5.3 Industry Trends
5.3.1 AI-Powered Diagnostics Go Mainstream
5.3.2 Cloud-based Platforms and Remote Access Become Critical Enablers
5.4 Technology Analysis
5.4.1 Cloud Storage & Archiving
5.4.2 Whole Slide Imaging (Wsi) Scanners
5.4.3 Image Management Systems
5.4.4 Adjacent Technologies
5.4.4.1 Genomic Sequencing
5.4.4.2 Artificial Intelligence and Machine Learning
5.4.5 Complementary Technologies
5.4.5.1 Lis & Pacs
5.5 Pricing Analysis
5.5.1 Average Selling Price Trend, by Region
5.5.2 Average Selling Price Trend of Key Players, by Product
5.6 Value Chain Analysis
5.7 Ecosystem Analysis
5.8 Porter's Five Forces Analysis
5.8.1 Threat of New Entrants
5.8.2 Threat of Substitutes
5.8.3 Bargaining Power of Suppliers
5.8.4 Bargaining Power of Buyers
5.8.5 Intensity of Competitive Rivalry
5.9 HS Codes
5.10 Regulatory Landscape
5.10.1 Regulatory Bodies, Government Agencies, and Other Organizations
5.10.2 Regulatory Analysis
5.10.2.1 North America
5.10.2.1.1 US
5.10.2.1.2 Canada
5.10.2.2 Europe
5.10.2.3 Asia-Pacific
5.10.2.3.1 Japan
5.10.2.3.2 China
5.10.2.3.3 India
5.11 Patent Analysis
5.11.1 Patent Publication Trends
5.11.2 Jurisdiction Analysis: Top Applicant Countries for Digital Pathology Patents
5.11.3 Major Patents
5.12 Case Study Analysis
5.13 Key Conferences & Events, 2025-2026
5.14 Key Stakeholders & Buying Criteria
5.14.1 Key Stakeholders in Buying Process
5.14.2 Buying Criteria
5.14.3 Trends and Disruptions Impacting Customer Business
5.15 End-user Analysis
5.15.1 Unmet Needs
5.15.2 End-user Expectations
5.16 Business Model Analysis
5.17 Investment & Funding Scenario
5.18 Impact of AI on Digital Pathology Market
5.19 Impact of US Tariff on Digital Pathology Market
5.19.1 Introduction
5.19.2 Key Tariff Rates
5.20 Price Impact Analysis
5.21 Impact on Country/Region
5.21.1 US
5.21.2 Europe
5.21.3 Asia-Pacific
5.21.4 Impact on End-use Industries

6.1 Introduction
6.2 Scanners
6.2.1 Brightfield Scanners
6.2.1.1 Cost-Efficient Features to Boost Demand
6.2.2 Fluorescence Scanners
6.2.2.1 Ability to Detect Cellular Structures and Biomarkers to Fuel Uptake
6.2.3 Other Scanners
6.3 Software
6.3.1 Integrated Software
6.3.1.1 Single & Effective Suite for Multiple Applications to Propel Market
6.3.2 Standalone Software
6.3.2.1 Information Management Software
6.3.2.1.1 Management of Image Repositories to Fuel Uptake
6.3.2.2 Image Analysis Software
6.3.2.2.1 Ability to Automate Quantitative Evaluation to Support Market Growth
6.4 Software, by Deployment Model
6.4.1 Cloud-based Model
6.4.1.1 Facilitation of Collaboration on a Single Platform to Drive Market
6.4.2 On-Premise Model
6.4.2.1 High Data Security and Integration with Hcit Solutions to Fuel Uptake
6.4.3 Hybrid Model
6.4.3.1 Combined Flexibility to Support Market Growth
6.5 Storage Systems
6.5.1 Growing Focus on Storage of High-Resolution Images to Drive Market

7.1 Introduction
7.2 Human Pathology
7.2.1 Increasing Cancer Research Activities to Propel Market
7.3 Veterinary Pathology
7.3.1 Improvements in Animal Disease Diagnostics to Support Market Growth

8.1 Introduction
8.2 Drug Discovery
8.2.1 Increasing Focus on Life Sciences R&D to Drive Market
8.3 Disease Diagnosis
8.3.1 Integration of AI & ML in Complex Diagnostics to Boost Demand
8.4 Training & Education
8.4.1 Ability to Provide Real-Time Learning Experiences to Support Market Growth

9.1 Introduction
9.2 Pharmaceutical & Biotechnology Companies
9.2.1 Increasing Focus on Drug Toxicology Testing and Rising Number of Preclinical Trials to Propel Market
9.3 Hospitals & Reference Laboratories
9.3.1 High Incidence of Infectious Diseases to Boost Demand
9.4 Academic & Research Institutes
9.4.1 Increasing Public & Private Funding Investments to Support Market Growth
9.5 Diagnostics Laboratories
9.5.1 Increasing Public & Private Funding Investments to Support Market Growth
9.6 Veterinary Laboratories
9.6.1 Technological Advancements, Particularly in Whole-Slide Imaging Systems and AI-Powered Image Analysis Software, Support Market Growth

10.1 Introduction
10.2 North America
10.2.1 North America: Macroeconomic Outlook
10.2.2 US
10.2.2.1 Favorable Reimbursements for Diagnostics to Drive Market
10.2.3 Canada
10.2.3.1 Growing Awareness on Early Cancer Detection & Diagnosis to Drive Market
10.3 Europe
10.3.1 Europe: Macroeconomic Outlook
10.3.2 Germany
10.3.2.1 High Healthcare Expenditure and Supportive Research Initiatives to Drive Market
10.3.3 UK
10.3.3.1 Government Funding Investments for Pathology Services to Fuel Market
10.3.4 Sweden
10.3.4.1 Increasing Prevalence of Chronic Diseases to Support Market Growth
10.3.5 France
10.3.5.1 Increasing Government Funding and Favorable Insurance System to Drive Adoption
10.3.6 Spain
10.3.6.1 Supportive Collaborations Among Leading Companies and Hospitals to Boost Demand
10.3.7 Italy
10.3.7.1 Integration of AI & ML to Support Market Growth
10.3.8 Rest of Europe
10.4 Asia-Pacific
10.4.1 Asia-Pacific: Macroeconomic Outlook
10.4.2 China
10.4.2.1 Increasing Establishment of Hospitals and Reference Laboratories to Drive Market
10.4.3 Japan
10.4.3.1 Advanced Healthcare Infrastructure to Support Market Growth
10.4.4 India
10.4.4.1 Growth in Pharmaceutical Industry to Propel Market
10.4.5 Rest of Asia-Pacific
10.5 Latin America
10.5.1 Latin America: Macroeconomic Outlook
10.5.2 Brazil
10.5.2.1 High Adoption of Poc Testing to Drive Market
10.5.3 Mexico
10.5.3.1 Growth in Companion Diagnostics to Fuel Uptake
10.5.4 Rest of Latin America
10.6 Middle East & Africa
10.6.1 Improvements in Healthcare Infrastructure to Support Market Growth
10.6.2 Macroeconomic Outlook for Middle East & Africa
10.6.3 GCC Countries
10.6.4 Rest of Middle East & Africa

11.1 Overview
11.2 Key Player Strategy/Right to Win
11.2.1 Overview of Strategies Adopted by Players in Digital Pathology Market
11.3 Revenue Analysis
11.4 Market Share Analysis
11.5 Company Evaluation Matrix: Key Players, 2023
11.5.1 Stars
11.5.2 Emerging Leaders
11.5.3 Pervasive Players
11.5.4 Participants
11.5.5 Company Footprint: Key Players, 2024
11.5.5.1 Company Footprint
11.5.5.2 Product Footprint
11.5.5.3 Application Footprint
11.5.5.4 End-user Footprint
11.5.5.5 Region Footprint
11.6 Company Evaluation Matrix: Startups/SMEs, 2023
11.6.1 Progressive Companies
11.6.2 Responsive Companies
11.6.3 Dynamic Companies
11.6.4 Starting Blocks
11.6.5 Competitive Benchmarking: Startups/SMEs, 2024
11.7 Company Valuation and Financial Metrics
11.8 Brand/Software Comparative Analysis
11.9 Competitive Scenario
11.9.1 Product Launches, Enhancements, and Approvals
11.9.2 Deals
11.9.3 Other Developments

12.1 Key Companies
12.1.1 Danaher Corporation
12.1.1.1 Business Overview
12.1.1.2 Products Offered
12.1.1.3 Recent Developments
12.1.1.3.1 Deals
12.1.1.4 Analyst's View
12.1.1.4.1 Key Strengths
12.1.1.4.2 Strategic Choices
12.1.1.4.3 Weaknesses and Competitive Threats
12.1.2 Hoffmann-La Roche Ltd.
12.1.2.1 Business Overview
12.1.2.2 Products Offered
12.1.2.3 Recent Developments
12.1.2.3.1 Product Launches & Approvals
12.1.2.3.2 Deals
12.1.2.4 Analyst's View
12.1.2.4.1 Key Strengths
12.1.2.4.2 Strategic Choices
12.1.2.4.3 Weaknesses and Competitive Threats
12.1.3 Sectra Ab
12.1.3.1 Business Overview
12.1.3.2 Products Offered
12.1.3.3 Recent Developments
12.1.3.3.1 Deals
12.1.3.3.2 Other Developments
12.1.3.4 Analyst's View
12.1.3.4.1 Key Strengths
12.1.3.4.2 Strategic Choices
12.1.3.4.3 Weaknesses and Competitive Threats
12.1.4 Hamamatsu Photonics K.K.
12.1.4.1 Business Overview
12.1.4.2 Products Offered
12.1.4.3 Recent Developments
12.1.4.3.1 Product Approvals
12.1.4.3.2 Deals
12.1.4.4 Analyst's View
12.1.4.4.1 Key Strengths
12.1.4.4.2 Strategic Choices
12.1.4.4.3 Weaknesses and Competitive Threats
12.1.5 Koninklijke Philips N.V.
12.1.5.1 Business Overview
12.1.5.2 Products Offered
12.1.5.3 Recent Developments
12.1.5.3.1 Product Launches & Approvals
12.1.5.3.2 Deals
12.1.5.4 Analyst's View
12.1.5.4.1 Key Strengths
12.1.5.4.2 Strategic Choices
12.1.5.4.3 Weaknesses and Competitive Threats
12.1.6 Akoya Biosciences, Inc.
12.1.6.1 Business Overview
12.1.6.2 Products Offered
12.1.6.3 Recent Developments
12.1.6.3.1 Product Launches & Approvals
12.1.7 Fujifilm Holdings Corporation
12.1.7.1 Business Overview
12.1.7.2 Products Offered
12.1.7.3 Recent Developments
12.1.7.3.1 Deals
12.1.8 Hologic, Inc.
12.1.8.1 Business Overview
12.1.8.2 Products Offered
12.1.8.3 Recent Developments
12.1.8.3.1 Product Approvals
12.1.9 3Dhistech Ltd.
12.1.9.1 Business Overview
12.1.9.2 Products Offered
12.1.9.3 Recent Developments
12.1.9.3.1 Product Launches & Enhancements
12.1.9.3.2 Other Developments
12.1.10 Apollo Enterprise Imaging Corp.
12.1.10.1 Business Overview
12.1.10.2 Products Offered
12.1.10.3 Recent Developments
12.1.10.3.1 Product Enhancements
12.1.10.3.2 Deals
12.1.11 Xifin, Inc.
12.1.11.1 Business Overview
12.1.11.2 Products Offered
12.1.11.3 Recent Developments
12.1.11.3.1 Product Launches
12.1.11.3.2 Deals
12.1.12 Huron Digital Pathology
12.1.12.1 Business Overview
12.1.12.2 Products Offered
12.1.12.2.1 Deals
12.1.13 Indica Labs
12.1.13.1 Business Overview
12.1.13.2 Products Offered
12.1.13.3 Recent Developments
12.1.13.3.1 Product Launches & Approvals
12.1.13.3.2 Deals
12.1.14 Optrascan, Inc.
12.1.14.1 Business Overview
12.1.14.2 Products Offered
12.1.14.3 Recent Developments
12.1.14.3.1 Product Launches & Approvals
12.1.14.3.2 Deals
12.1.15 Glencoe Software, Inc.
12.1.15.1 Business Overview
12.1.15.2 Products Offered
12.1.15.3 Recent Developments
12.1.15.3.1 Product Enhancements
12.1.16 Aiforia Technologies Oy
12.1.16.1 Business Overview
12.1.16.2 Products Offered
12.1.16.3 Recent Developments
12.1.16.3.1 Deals
12.1.17 Paige AI, Inc.
12.1.17.1 Business Overview
12.1.17.2 Products Offered
12.1.17.3 Recent Developments
12.1.17.3.1 Product Launches & Enhancements
12.1.17.3.2 Deals
12.1.18 Proscia, Inc.
12.1.18.1 Business Overview
12.1.18.2 Products Offered
12.1.18.3 Recent Developments
12.1.18.3.1 Product Enhancements & Approvals
12.1.18.3.2 Deals
12.2 Other Players
12.2.1 Quest Diagnostics
12.2.2 Konfoong Biotech International Co. Ltd.
12.2.3 Mikroscan Technologies, Inc.
12.2.4 Motic Digital Pathology
12.2.5 Kanteron Systems
12.2.6 Morphle Labs Inc.
12.2.7 Ew Healthcare Partners

13.1 Discussion Guide
13.2 Knowledgestore: The Subscription Portal
13.3 Customization Options

Table 1 Factor Analysis
Table 2 Risk Assessment Analysis
Table 3 Incidence of Cancer, by Region, 2020 vs. 2030 vs. 2040 (Million)
Table 4 Average Selling Price Trend of Digital Pathology Products, by Region
Table 5 Average Selling Price of Digital Pathology Products
Table 6 Digital Pathology Market: Porter's Five Forces
Table 7 Regulatory Bodies, Government Agencies, and Other Organizations
Table 8 US Fda: Medical Device Classification
Table 9 US: Medical Device Regulatory Approval Process
Table 10 Canada: Medical Device Regulatory Approval Process
Table 11 Europe: Classification of Ivd Devices
Table 12 Japan: Medical Device Classification Under Pmda
Table 13 China: Classification of Medical Devices
Table 14 List of Patents/Patent Applications
Table 15 Case Study 1: Assessing Image Quality: a Comparative Multi-Assessment Evaluation of Aperio Gt 450 Dx
Table 16 Case Study 2: How to Promote Pathology Workflow Efficiency
Table 17 Case Study 3: Artificial Intelligence in Digital Pathology
Table 18 Influence of Stakeholders on Buying Process for Digital Pathology Products
Table 19 Influence of Stakeholders on Buying Process for Digital Pathology, by Product
Table 20 Key Buying Criteria for Digital Pathology Products
Table 21 Unmet Needs in Digital Pathology Market
Table 22 End-user Expectations in Digital Pathology Market
Table 23 US-Adjusted Reciprocal Tariff Rates
Table 24 Digital Pathology Market, by Product, 2023-2030 (USD Million)
Table 25 Scanning Magnification and Applications
Table 26 Digital Pathology Scanners Offered by Key Market Players
Table 27 Digital Pathology Market for Scanners, by Type, 2023-2030 (USD Million)
Table 28 Digital Pathology Market for Scanners, by Region, 2023-2030 (USD Million)
Table 29 Brightfield Scanners Offered by Key Market Players
Table 30 Brightfield Scanners Market, by Region, 2023-2030 (USD Million)
Table 31 Fluorescence Scanners Offered by Key Market Players
Table 32 Fluorescence Scanners Market, by Region, 2023-2030 (USD Million)
Table 33 Other Scanners Offered by Key Market Players
Table 34 Other Scanners Market, by Region, 2023-2030 (USD Million)
Table 35 Digital Pathology Software Offered by Key Market Players
Table 36 Digital Pathology Market for Software, by Type, 2023-2030 (USD Million)
Table 37 Digital Pathology Market for Software, by Region, 2023-2030 (USD Million)
Table 38 Integrated Software Offered by Key Market Players
Table 39 Integrated Software Market, by Region, 2023-2030 (USD Million)
Table 40 Standalone Software Market, by Type, 2023-2030 (USD Million)
Table 41 Standalone Software Market, by Region, 2023-2030 (USD Million)
Table 42 Information Management Software Offered by Key Market Players
Table 43 Information Management Software Market, by Region, 2023-2030 (USD Million)
Table 44 Image Analysis Software Offered by Key Market Players
Table 45 Image Analysis Software Market, by Region, 2023-2030 (USD Million)
Table 46 Digital Pathology Market for Software, by Deployment Model, 2023-2030 (USD Million)
Table 47 Cloud-based Software Offered by Key Market Players
Table 48 Cloud-based Model Market, by Region, 2023-2030 (USD Million)
Table 49 On-Premise Software Offered by Key Market Players
Table 50 On-Premise Model Market, by Region, 2023-2030 (USD Million)
Table 51 Hybrid Software Offered by Key Market Players
Table 52 Hybrid Model Market, by Region, 2023-2030 (USD Million)
Table 53 Storage Systems Offered by Key Market Players
Table 54 Digital Pathology Market for Storage Systems, by Region, 2023-2030 (USD Million)
Table 55 Digital Pathology Market, by Type, 2023-2030 (USD Million)
Table 56 Human Digital Pathology Market, by Region, 2023-2030 (USD Million)
Table 57 Veterinary Digital Pathology Market, by Region, 2023-2030 (USD Million)
Table 58 Digital Pathology Market, by Application, 2023-2030 (USD Million)
Table 59 Software Impact Analysis, by Application
Table 60 Digital Pathology Applications in Drug Discovery
Table 61 Digital Pathology Market for Drug Discovery, by Region, 2023-2030 (USD Million)
Table 62 Digital Pathology Market for Disease Diagnosis, by Region, 2023-2030 (USD Million)
Table 63 Digital Pathology Market for Training & Education, by Region, 2023-2030 (USD Million)
Table 64 Digital Pathology Market, by End-user, 2023-2030 (USD Million)
Table 65 Digital Pathology Market: Software Impact Analysis, by End-user
Table 66 Digital Pathology Market for Pharmaceutical & Biotechnology Companies, by Region, 2023-2030 (USD Million)
Table 67 Deployment of Digital Pathology Solutions, by Hospital
Table 68 Digital Pathology Market for Hospitals & Reference Laboratories, by Region, 2023-2030 (USD Million)
Table 69 Digital Pathology Market for Academic & Research Institutes, by Region, 2023-2030 (USD Million)
Table 70 Digital Pathology Market for Diagnostics Laboratories, by Region, 2023-2030 (USD Million)
Table 71 Digital Pathology Market for Veterinary Laboratories, by Region, 2023-2030 (USD Million)
Table 72 Digital Pathology Market, by Region, 2023-2030 (USD Million)
Table 73 North America: Macroeconomic Outlook, 2024
Table 74 North America: Digital Pathology Market, by Country, 2023-2030 (USD Million)
Table 75 North America: Digital Pathology Market, by Product, 2023-2030 (USD Million)
Table 76 North America: Digital Pathology Market for Scanners, by Type, 2023-2030 (USD Million)
Table 77 North America: Digital Pathology Market for Software, by Type, 2023-2030 (USD Million)
Table 78 North America: Standalone Software Market, by Type, 2023-2030 (USD Million)
Table 79 North America: Digital Pathology Market for Software, by Deployment Model, 2023-2030 (USD Million)
Table 80 North America: Digital Pathology Market, by Type, 2023-2030 (USD Million)
Table 81 North America: Digital Pathology Market, by Application, 2023-2030 (USD Million)
Table 82 North America: Digital Pathology Market, by End-user, 2023-2030 (USD Million)
Table 83 US: Cancer Incidence, by Cancer Type, 2022 vs. 2040
Table 84 US: Digital Pathology Market, by Product, 2023-2030 (USD Million)
Table 85 US: Digital Pathology Market for Scanners, by Type, 2023-2030 (USD Million)
Table 86 US: Digital Pathology Market for Software, by Type, 2023-2030 (USD Million)
Table 87 US: Standalone Software Market, by Type, 2023-2030 (USD Million)
Table 88 US: Digital Pathology Market for Software, by Deployment Model, 2023-2030 (USD Million)
Table 89 Canada: Cancer Incidence, by Cancer Type, 2020 vs. 2040
Table 90 Canada: Funding Initiatives for Digital Pathology
Table 91 Canada: Key Macroindicators
Table 92 Canada: Digital Pathology Market, by Product, 2023-2030 (USD Million)
Table 93 Canada: Digital Pathology Market for Scanners, by Type, 2023-2030 (USD Million)
Table 94 Canada: Digital Pathology Market for Software, by Type, 2023-2030 (USD Million)
Table 95 Canada: Standalone Software Market, by Type, 2023-2030 (USD Million)
Table 96 Canada: Digital Pathology Market for Software, by Deployment Model, 2023-2030 (USD Million)
Table 97 Europe: Macroeconomic Outlook
Table 98 Europe: Digital Pathology Market, by Country, 2023-2030 (USD Million)
Table 99 Europe: Digital Pathology Market, by Product, 2023-2030 (USD Million)
Table 100 Europe: Digital Pathology Market for Scanners, by Type, 2023-2030 (USD Million)
Table 101 Europe: Digital Pathology Market for Software, by Type, 2023-2030 (USD Million)
Table 102 Europe: Standalone Software Market, by Type, 2023-2030 (USD Million)
Table 103 Europe: Digital Pathology Market for Software, by Deployment Model, 2023-2030 (USD Million)
Table 104 Europe: Digital Pathology Market, by Type, 2023-2030 (USD Million)
Table 105 Europe: Digital Pathology Market, by Application, 2023-2030 (USD Million)
Table 106 Europe: Digital Pathology Market, by End-user, 2023-2030 (USD Million)
Table 107 Germany: Cancer Incidence, by Cancer Type, 2020 vs. 2040
Table 108 Germany: Key Macroindicators
Table 109 Germany: Digital Pathology Market, by Product, 2023-2030 (USD Million)
Table 110 Germany: Digital Pathology Market for Scanners, by Type, 2023-2030 (USD Million)
Table 111 Germany: Digital Pathology Market for Software, by Type, 2023-2030 (USD Million)
Table 112 Germany: Standalone Software Market, by Type, 2023-2030 (USD Million)
Table 113 Germany: Digital Pathology Market for Software, by Deployment Model, 2023-2030 (USD Million)
Table 114 UK: Cancer Incidence, by Cancer Type, 2020 vs. 2040
Table 115 UK: Key Macroindicators
Table 116 UK: Digital Pathology Market, by Product, 2023-2030 (USD Million)
Table 117 UK: Digital Pathology Market for Scanners, by Type, 2023-2030 (USD Million)
Table 118 UK: Digital Pathology Market for Software, by Type, 2023-2030 (USD Million)
Table 119 UK: Standalone Software Market, by Type, 2023-2030 (USD Million)
Table 120 UK: Digital Pathology Market for Software, by Deployment Model, 2023-2030 (USD Million)
Table 121 Sweden: Cancer Incidence, by Cancer Type, 2020 vs. 2040
Table 122 Sweden: Key Macroindicators
Table 123 Sweden: Digital Pathology Market, by Product, 2023-2030 (USD Million)
Table 124 Sweden: Digital Pathology Market for Scanners, by Type, 2023-2030 (USD Million)
Table 125 Sweden: Digital Pathology Market for Software, by Type, 2023-2030 (USD Million)
Table 126 Sweden: Standalone Software Market, by Type, 2023-2030 (USD Million)
Table 127 Sweden: Digital Pathology Market for Software, by Deployment Model, 2023-2030 (USD Million)
Table 128 France: Cancer Incidence, by Cancer Type, 2020 vs. 2040
Table 129 France: Digital Pathology Market, by Product, 2023-2030 (USD Million)
Table 130 France: Digital Pathology Market for Scanners, by Type, 2023-2030 (USD Million)
Table 131 France: Digital Pathology Market for Software, by Type, 2023-2030 (USD Million)
Table 132 France: Standalone Software Market, by Type, 2023-2030 (USD Million)
Table 133 France: Digital Pathology Market for Software, by Deployment Model, 2023-2030 (USD Million)
Table 134 Spain: Digital Pathology Market, by Product, 2023-2030 (USD Million)
Table 135 Spain: Digital Pathology Market for Scanners, by Type, 2023-2030 (USD Million)
Table 136 Spain: Digital Pathology Market for Software, by Type, 2023-2030 (USD Million)
Table 137 Spain: Standalone Software Market, by Type, 2023-2030 (USD Million)
Table 138 Spain: Digital Pathology Market for Software, by Deployment Model, 2023-2030 (USD Million)
Table 139 Italy: Digital Pathology Market, by Product, 2023-2030 (USD Million)
Table 140 Italy: Digital Pathology Market for Scanners, by Type, 2023-2030 (USD Million)
Table 141 Italy: Digital Pathology Market for Software, by Type, 2023-2030 (USD Million)
Table 142 Italy: Standalone Software Market, by Type, 2023-2030 (USD Million)
Table 143 Italy: Digital Pathology Market for Software, by Deployment Model, 2023-2030 (USD Million)
Table 144 Rest of Europe: Digital Pathology Market, by Product, 2023-2030 (USD Million)
Table 145 Rest of Europe: Digital Pathology Market for Scanners, by Type, 2023-2030 (USD Million)
Table 146 Rest of Europe: Digital Pathology Market for Software, by Type, 2023-2030 (USD Million)
Table 147 Rest of Europe: Standalone Software Market, by Type, 2023-2030 (USD Million)
Table 148 Rest of Europe: Digital Pathology Market for Software, by Deployment Model, 2023-2030 (USD Million)
Table 149 Asia-Pacific: Macroindicators
Table 150 Asia-Pacific: Digital Pathology Market, by Country, 2023-2030 (USD Million)
Table 151 Asia-Pacific: Digital Pathology Market, by Product, 2023-2030 (USD Million)
Table 152 Asia-Pacific: Digital Pathology Market for Scanners, by Type, 2023-2030 (USD Million)
Table 153 Asia-Pacific: Digital Pathology Market for Software, by Type, 2023-2030 (USD Million)
Table 154 Asia-Pacific: Standalone Software Market, by Type, 2023-2030 (USD Million)
Table 155 Asia-Pacific: Digital Pathology Market for Software, by Deployment Model, 2023-2030 (USD Million)
Table 156 Asia-Pacific: Digital Pathology Market, by Type, 2023-2030 (USD Million)
Table 157 Asia-Pacific: Digital Pathology Market, by Application, 2023-2030 (USD Million)
Table 158 Asia-Pacific: Digital Pathology Market, by End-user, 2023-2030 (USD Million)
Table 159 China: Cancer Incidence, by Cancer Type, 2020 vs. 2040
Table 160 China: Digital Pathology Market, by Product, 2023-2030 (USD Million)
Table 161 China: Digital Pathology Market for Scanners, by Type, 2023-2030 (USD Million)
Table 162 China: Digital Pathology Market for Software, by Type, 2023-2030 (USD Million)
Table 163 China: Standalone Software Market, by Type, 2023-2030 (USD Million)
Table 164 China: Digital Pathology Market for Software, by Deployment Model, 2023-2030 (USD Million)
Table 165 Japan: Cancer Incidence, by Cancer Type, 2020 vs. 2040
Table 166 Japan: Digital Pathology Market, by Product, 2023-2030 (USD Million)
Table 167 Japan: Digital Pathology Market for Scanners, by Type, 2023-2030 (USD Million)
Table 168 Japan: Digital Pathology Market for Software, by Type, 2023-2030 (USD Million)
Table 169 Japan: Standalone Software Market, by Type, 2023-2030 (USD Million)
Table 170 Japan: Digital Pathology Market for Software, by Deployment Model, 2023-2030 (USD Million)
Table 171 India: Cancer Incidence, by Cancer Type, 2020 vs. 2040
Table 172 India: Digital Pathology Market, by Product, 2023-2030 (USD Million)
Table 173 India: Digital Pathology Market for Scanners, by Type, 2023-2030 (USD Million)
Table 174 India: Digital Pathology Market for Software, by Type, 2023-2030 (USD Million)
Table 175 India: Standalone Software Market, by Type, 2023-2030 (USD Million)
Table 176 India: Digital Pathology Market for Software, by Deployment Model, 2023-2030 (USD Million)
Table 177 Rest of Asia-Pacific: Digital Pathology Market, by Product, 2023-2030 (USD Million)
Table 178 Rest of Asia-Pacific: Digital Pathology Market for Scanners, by Type, 2023-2030 (USD Million)
Table 179 Rest of Asia-Pacific: Digital Pathology Market for Software, by Type, 2023-2030 (USD Million)
Table 180 Rest of Asia-Pacific: Standalone Software Market, by Type, 2023-2030 (USD Million)
Table 181 Rest of Asia-Pacific: Digital Pathology Market for Software, by Deployment Model, 2023-2030 (USD Million)
Table 182 Latin America: Macroindicators
Table 183 Latin America: Digital Pathology Market, by Country, 2023-2030 (USD Million)
Table 184 Latin America: Digital Pathology Market, by Product, 2023-2030 (USD Million)
Table 185 Latin America: Digital Pathology Market for Scanners, by Type, 2023-2030 (USD Million)
Table 186 Latin America: Digital Pathology Market for Software, by Type, 2023-2030 (USD Million)
Table 187 Latin America: Standalone Software Market, by Type, 2023-2030 (USD Million)
Table 188 Latin America: Digital Pathology Market for Software, by Deployment Model, 2023-2030 (USD Million)
Table 189 Latin America: Digital Pathology Market, by Type, 2023-2030 (USD Million)
Table 190 Latin America: Digital Pathology Market, by Application, 2023-2030 (USD Million)
Table 191 Latin America: Digital Pathology Market, by End-user, 2023-2030 (USD Million)
Table 192 Brazil: Cancer Incidence, by Cancer Type, 2020 vs. 2040
Table 193 Brazil: Digital Pathology Market, by Product, 2023-2030 (USD Million)
Table 194 Brazil: Digital Pathology Market for Scanners, by Type, 2023-2030 (USD Million)
Table 195 Brazil: Digital Pathology Market for Software, by Type, 2023-2030 (USD Million)
Table 196 Brazil: Standalone Software Market, by Type, 2023-2030 (USD Million)
Table 197 Brazil: Digital Pathology Market for Software, by Deployment Model, 2023-2030 (USD Million)
Table 198 Mexico: Cancer Incidence, by Cancer Type, 2020 vs. 2040
Table 199 Mexico: Digital Pathology Market, by Product, 2023-2030 (USD Million)
Table 200 Mexico: Digital Pathology Market for Scanners, by Type, 2023-2030 (USD Million)
Table 201 Mexico: Digital Pathology Market for Software, by Type, 2023-2030 (USD Million)
Table 202 Mexico: Standalone Software Market, by Type, 2023-2030 (USD Million)
Table 203 Mexico: Digital Pathology Market for Software, by Deployment Model, 2023-2030 (USD Million)
Table 204 Rest of Latin America: Digital Pathology Market, by Product, 2023-2030 (USD Million)
Table 205 Rest of Latin America: Digital Pathology Market for Scanners, by Type, 2023-2030 (USD Million)
Table 206 Rest of Latin America: Digital Pathology Market for Software, by Type, 2023-2030 (USD Million)
Table 207 Rest of Latin America: Standalone Software Market, by Type, 2023-2030 (USD Million)
Table 208 Rest of Latin America: Digital Pathology Market for Software, by Deployment Model, 2023-2030 (USD Million)
Table 209 Middle East & Africa: Key Macroindicators
Table 210 Middle East & Africa: Digital Pathology Market, by Country, 2023-2030 (USD Million)
Table 211 Middle East & Africa: Digital Pathology Market, by Product, 2023-2030 (USD Million)
Table 212 Middle East & Africa: Digital Pathology Market for Scanners, by Type, 2023-2030 (USD Million)
Table 213 Middle East & Africa: Digital Pathology Market for Software, by Type, 2023-2030 (USD Million)
Table 214 Middle East & Africa: Standalone Software Market, by Type, 2023-2030 (USD Million)
Table 215 Middle East & Africa: Digital Pathology Market for Software, by Deployment Model, 2023-2030 (USD Million)
Table 216 Middle East & Africa: Digital Pathology Market, by Type, 2023-2030 (USD Million)
Table 217 Middle East & Africa: Digital Pathology Market, by Application, 2023-2030 (USD Million)
Table 218 Middle East & Africa: Digital Pathology Market, by End-user, 2023-2030 (USD Million)
Table 219 GCC: Digital Pathology Market, by Product, 2023-2030 (USD Million)
Table 220 GCC: Digital Pathology Market for Scanners, by Type, 2023-2030 (USD Million)
Table 221 GCC: Digital Pathology Market for Software, by Type, 2023-2030 (USD Million)
Table 222 GCC: Standalone Software Market, by Type, 2023-2030 (USD Million)
Table 223 GCC: Digital Pathology Market for Software, by Deployment Model, 2023-2030 (USD Million)
Table 224 Rest of Middle East & Africa: Digital Pathology Market, by Product, 2023-2030 (USD Million)
Table 225 Rest of Middle East & Africa: Digital Pathology Market for Scanners, by Type, 2023-2030 (USD Million)
Table 226 Rest of Middle East & Africa: Digital Pathology Market for Software, by Type, 2023-2030 (USD Million)
Table 227 Rest of Middle East & Africa: Standalone Software Market, by Type, 2023-2030 (USD Million)
Table 228 Rest of Middle East & Africa: Digital Pathology Market for Software, by Deployment Model, 2023-2030 (USD Million)
Table 229 Overview of Strategies Deployed by Key Manufacturing Companies
Table 230 Digital Pathology Market: Degree of Competition
Table 231 Digital Pathology Market: Product Footprint
Table 232 Digital Pathology Market: Application Footprint
Table 233 Digital Pathology Market: End-user Footprint
Table 234 Digital Pathology Market: Region Footprint
Table 235 Digital Pathology Market: Detailed List of Key Start-Ups/SMEs
Table 236 Digital Pathology Market: Competitive Benchmarking of Key Emerging Players/Startups
Table 237 Digital Pathology Market: Product Launches, Enhancements, and Approvals, January 2022-June 2025
Table 238 Digital Pathology Market: Deals, January 2022-June 2025
Table 239 Digital Pathology Market: Other Developments, January 2022-June 2025
Table 240 Danaher Corporation: Company Overview
Table 241 Danaher Corporation: Products Offered
Table 242 Danaher Corporation: Deals, January 2022-June 2025
Table 243 F. Hoffmann-La Roche Ltd.: Company Overview
Table 244 F. Hoffmann-La Roche Ltd.: Products Offered
Table 245 Hoffmann-La Roche Ltd.: Product Launches & Approvals, January 2022-June 2025
Table 246 Hoffmann-La Roche Ltd.: Deals, January 2022-June 2025
Table 247 Sectra Ab: Company Overview
Table 248 Sectra Ab: Products Offered
Table 249 Sectra Ab: Deals, January 2022-June 2025
Table 250 Sectra Ab: Other Developments, January 2022-June 2025
Table 251 Hamamatsu Photonics K.K.: Company Overview
Table 252 Hamamatsu Photonics K.K.: Products Offered
Table 253 Hamamatsu Photonics K.K.: Product Approvals, January 2022-June 2025
Table 254 Hamamatsu Photonics K.K.: Deals, January 2022-June 2025
Table 255 Koninklijke Philips N.V.: Company Overview
Table 256 Koninklijke Philips N.V.: Products Offered
Table 257 Koninklijke Philips N.V: Product Approvals, January 2022-June 2025
Table 258 Koninklijke Philips N.V.: Deals, January 2022-June 2025
Table 259 Akoya Biosciences, Inc.: Company Overview
Table 260 Akoya Biosciences Inc.: Products Offered
Table 261 Akoya Biosciences, Inc.: Product Launches & Approvals, January 2022-June 2024
Table 262 Fujifilm Holdings Corporation: Company Overview
Table 263 Fujifilm Holdings Corporation: Products Offered
Table 264 Fujifilm Holdings Corporation: Deals, January 2022-June 2025
Table 265 Hologic, Inc.: Company Overview
Table 266 Hologic, Inc.: Products Offered
Table 267 Hologic, Inc.: Product Approvals, January 2022-June 2025
Table 268 3Dhistech Ltd.: Company Overview
Table 269 3Dhistech Ltd.: Products Offered
Table 270 3Dhistech Ltd.: Product Launches & Enhancements, January 2022-June 2024
Table 271 3Dhistech Ltd.: Other Developments, January 2022-June 2024
Table 272 Apollo Enterprise Imaging Corp.: Company Overview
Table 273 Apollo Enterprise Imaging Corp.: Products Offered
Table 274 Apollo Enterprise Imaging Corp.: Product Enhancements, January 2022-June 2025
Table 275 Apollo Enterprise Imaging Corp.: Deals, January 2022-June 2025
Table 276 Xifin, Inc.: Company Overview
Table 277 Xifin, Inc.: Products Offered
Table 278 Xifin, Inc.: Product Launches, January 2022-June 2025
Table 279 Xifin, Inc.: Deals, January 2022-June 2025
Table 280 Huron Digital Pathology: Company Overview
Table 281 Huron Digital Pathology: Products Offered
Table 282 Huron Digital Pathology: Deals, January 2022-June 2025
Table 283 Indica Labs: Company Overview
Table 284 Indica Labs: Products Offered
Table 285 Indica Labs: Product Launches & Approvals, January 2022-June 2025
Table 286 Indica Labs: Deals, January 2022-June 2025
Table 287 Optrascan, Inc.: Company Overview
Table 288 Optrascan, Inc.: Products Offered
Table 289 Optrascan, Inc.: Product Launches & Approvals, January 2022-June 2025
Table 290 Optrascan, Inc.: Deals, January 2022-June 2025
Table 291 Glencoe Software, Inc.: Company Overview
Table 292 Glencoe Software, Inc.: Products Offered
Table 293 Glencoe Software, Inc.: Product Enhancements, January 2022-June 2025
Table 294 Aiforia Technologies Oy: Company Overview
Table 295 Aiforia Technologies Oy: Products Offered
Table 296 Paige AI, Inc.: Company Overview
Table 297 Paige AI, Inc.: Products Offered
Table 298 Paige AI, Inc.: Product Launches & Enhancements, January 2022-June 2025
Table 299 Paige AI, Inc.: Deals, January 2022-June 2025
Table 300 Proscia, Inc.: Company Overview
Table 301 Proscia, Inc.: Products Offered
Table 302 Proscia, Inc.: Product Enhancements & Approvals, January 2022-June 2025
Table 303 Proscia, Inc.: Deals, January 2022-June 2025
Table 304 Quest Diagnostics: Company Overview
Table 305 Konfoong Biotech International Co. Ltd.: Company Overview
Table 306 Mikroscan Technologies, Inc.: Company Overview
Table 307 Motic Digital Pathology: Company Overview
Table 308 Kanteron Systems: Company Overview
Table 309 Morphle Labs Inc.: Company Overview
Table 310 Ew Healthcare Partners: Company Overview

Figure 1 Digital Pathology Market
Figure 2 Research Design
Figure 3 Primary Sources
Figure 4 Breakdown of Primary Interviews, by Company Type, Designation, and Region
Figure 5 Research Methodology: Hypothesis Building
Figure 6 Market Size Estimation: Revenue Share Analysis
Figure 7 Digital Pathology Market: Revenue Share Analysis of Danaher Corporation
Figure 8 Bottom-Up Approach
Figure 9 CAGR Projections: Supply-Side Analysis
Figure 10 CAGR Projections from Analysis of Drivers, Restraints, Opportunities, and Challenges in Digital Pathology Market (2025-2030)
Figure 11 Data Triangulation Methodology
Figure 12 Digital Pathology Market, by Product, 2025 vs. 2030 (USD Million)
Figure 13 Digital Pathology Market, by Type, 2025 vs. 2030 (USD Million)
Figure 14 Digital Pathology Market, by Application, 2025 vs. 2030 (USD Million)
Figure 15 Digital Pathology Market, by End-user, 2025 vs. 2030 (USD Million)
Figure 16 Geographic Snapshot of Digital Pathology Market
Figure 17 Rising Incidence of Cancer and Growing Adoption of Pathology Solutions for Enhanced Lab Efficiency to Drive Market
Figure 18 Pharmaceutical & Biotechnology Companies Accounted for Largest Market Share in 2024
Figure 19 UK to Grow at Highest CAGR During Forecast Period
Figure 20 Asia-Pacific Segment to Dominate Market During Forecast Period
Figure 21 Digital Pathology Market: Drivers, Restraints, Opportunities, and Challenges
Figure 22 Global Cancer Incidence, 2008-2030
Figure 23 Fda-Approved Personalized Medicines, 2015-2022
Figure 24 Digital Pathology Market: Value Chain Analysis
Figure 25 Digital Pathology Market: Ecosystem Analysis
Figure 26 Digital Pathology Market: Porter's Five Forces Analysis
Figure 27 Europe: Ivdr Timeline
Figure 28 Jurisdiction Analysis: Top Applicant Countries for Digital Pathology Patents, 2014-2025
Figure 29 Major Patents for Digital Pathology (2015-2025)
Figure 30 Key Buying Criteria for Digital Pathology Products
Figure 31 Trends and Disruptions Impacting Customer Business
Figure 32 Recent Funding of Players in Digital Pathology Market
Figure 33 North America: Digital Pathology Market Snapshot
Figure 34 Asia-Pacific: Digital Pathology Market Snapshot
Figure 35 Revenue Analysis of Key Players in Digital Pathology Market
Figure 36 Digital Pathology Market Share Analysis
Figure 37 Digital Pathology Market: Company Evaluation Matrix (Key Players), 2023
Figure 38 Digital Pathology Market: Company Footprint
Figure 39 Digital Pathology Market: Company Evaluation Matrix (Startups/SMEs), 2024
Figure 40 EV/EBITDA of Key Vendors
Figure 41 Year-To-Date (YTD) Price Total Return and 5-Year Stock Beta of Digital Pathology Vendors
Figure 42 Digital Pathology Market: Brand/Software Comparative Analysis
Figure 43 Danaher Corporation: Company Snapshot (2024)
Figure 44 F. Hoffmann-La Roche Ltd.: Company Snapshot (2024)
Figure 45 Sectra Ab: Company Snapshot (2024)
Figure 46 Hamamatsu Photonics K.K.: Company Snapshot (2024)
Figure 47 Koninklijke Philips N.V.: Company Snapshot (2024)
Figure 48 Akoya Biosciences, Inc.: Company Snapshot (2024)
Figure 49 Fujifilm Holdings Corporation: Company Snapshot (2022)
Figure 50 Hologic, Inc.: Company Snapshot (2024)